Pharmacoepigenomics in colorectal cancer: a step forward in predicting prognosis and treatment response. - Wikidata - wikimedia - TriplyDB

Pharmacoepigenomics in colorectal cancer: a step forward in predicting prognosis and treatment response.

Pharmacoepigenomics in colorectal cancer: a step forward in predicting prognosis and treatment response.

http://www.wikidata.org/entity/Q37346216

about

Epigenetics advancing personalized nanomedicine in cancer therapy Genetic polymorphisms in MicroRNA-related genes as predictors of clinical outcomes in colorectal adenocarcinoma patients.Promoter hypermethylation of tumour suppressor genes as potential biomarkers in colorectal cancer.Predictive and prognostic biomarkers with therapeutic targets in advanced colorectal cancer.Promoter CpG island methylation markers in colorectal cancer: the road ahead.Body size and risk for colorectal cancers showing BRAF mutations or microsatellite instability: a pooled analysis.A let-7 microRNA SNP in the KRAS 3'UTR is prognostic in early-stage colorectal cancer.Pharmacoepigenetics and pharmacoepigenomics of gastrointestinal cancers.Prognostic DNA methylation markers for sporadic colorectal cancer: a systematic review.

P2860

Q27010637-2881FFC7-5211-44AF-9386-4EFE394623E4 Q34078876-3161255E-8FDE-47C5-ADE0-B73638AE2A93 Q35138892-EEC76945-3D63-4FD0-A9F1-81BB57A53A55 Q37697540-D11BA172-2B10-4D28-90DA-7EF246254E60 Q37997086-9B71B032-B08D-4E98-B927-D9EA9541B39F Q38403904-257E96B2-FCFA-45FB-AEEA-CFB7275E3E60 Q43496062-2068EE66-3B54-4C15-B554-FEF70F7D45C4 Q50252299-2CB4D460-C17A-412F-801C-6E823BCA4DDB Q52802632-F13B1983-AB29-4ADC-9277-4CCEFBBE0C18

P2860

Pharmacoepigenomics in colorectal cancer: a step forward in predicting prognosis and treatment response.

http://www.wikidata.org/entity/Q37346216

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on December 2008

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Pharmacoepigenomics in colorec ...... gnosis and treatment response.

@en

Pharmacoepigenomics in colorec ...... gnosis and treatment response.

@nl

type

label

Pharmacoepigenomics in colorec ...... gnosis and treatment response.

@en

Pharmacoepigenomics in colorec ...... gnosis and treatment response.

@nl

prefLabel

Pharmacoepigenomics in colorec ...... gnosis and treatment response.

@en

Pharmacoepigenomics in colorec ...... gnosis and treatment response.

@nl

P1433

Q37346216-9B92B0BD-5035-45B6-B57A-C70348CAC91A

P1476

Q37346216-B87B483C-0916-4ECE-9ECA-BA878F1620E0

P2093

Q37346216-355825A5-E41F-42D0-907D-0DA71D57D957

Q37346216-4EC961D0-EF2A-4B35-BBFD-88F576B173DA

Q37346216-7D52BED9-0641-4F64-8349-86C34CB65A8A

Q37346216-981DAF0F-540B-4000-A5EE-49C3D2A89F3B

Q37346216-ABAE3FA3-6067-4744-B26D-AF884B7F483F

Q37346216-B88522CC-757F-40C4-BF34-775DA3BD0675

Q37346216-F2820537-2FD7-4365-9A89-382AE68C74D6

P2860

Q37346216-02D47C80-30E5-4767-BAEB-46FDEDC7F05C

Q37346216-059DAC20-BD78-4BA4-A0C5-3FCD7F53C44C

Q37346216-06108DB4-EF47-4BFE-8130-24177A8AF39D

Q37346216-061BD3FA-77CC-407B-A44A-1307056871FD

Q37346216-066C0EBF-2DDA-4F27-8E1B-FA367204B753

Q37346216-08AF1B3C-C412-41E6-8163-27B6074E5F33

Q37346216-0B9D2DFA-1D26-45BD-B9D9-DEAA70F78059

Q37346216-0CEF6429-731A-41AE-9076-65891ABBE075

Q37346216-10F521CC-D7C1-4E2A-B103-EE6CB0D123D2

Q37346216-111C31E6-32FE-4679-A7D4-D5948B3A885D

P304

Q37346216-CCC44435-B652-4065-AB45-5BD939B09134

P31

Q37346216-C232C0CC-53E5-4D22-AAFA-57466FAAC253

P356

Q37346216-A90E482D-314A-4AC0-BDD6-0AD2592206F6

P433

Q37346216-46CFAEC1-237B-43B0-98B9-01847B25BC60

P478

Q37346216-2270641A-3D58-4D92-B23B-B7FAE3B2526F

P50

Q37346216-A1988C69-47CA-432E-9E40-4CAFE4B296AD

P577

Q37346216-2A7492CC-0B6F-44CB-97B3-B4DC7AC8D6E4

P5875

Q37346216-207DBD3B-5D7F-4FC2-A764-34C058570351

P698

Q37346216-A7C50C41-4AAF-475B-BC95-6353E4BCAD6C

P921

Q37346216-6E7BEA0D-3757-4846-B707-482664023451

P356

14622416.9.12.1903

P1433

Pharmacogenomics

P1476

Pharmacoepigenomics in colorec ...... gnosis and treatment response.

@en

P2093

Adriaan P de Bruïne

http://www.w3.org/2001/XMLSchema#string

Arjen H G Cleven

http://www.w3.org/2001/XMLSchema#string

James G Herman

http://www.w3.org/2001/XMLSchema#string

Kim M Smits

http://www.w3.org/2001/XMLSchema#string

Laura A E Hughes

http://www.w3.org/2001/XMLSchema#string

Manon van Engeland

http://www.w3.org/2001/XMLSchema#string

Matty P Weijenberg

http://www.w3.org/2001/XMLSchema#string

P2860

Why most published research findings are false

Chfr defines a mitotic stress checkpoint that delays entry into metaphase

A truncating mutation of HDAC2 in human cancers confers resistance to histone deacetylase inhibition

Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer

High sensitivity mapping of methylated cytosines

A Bayesian deconvolution strategy for immunoprecipitation-based DNA methylome analysis

Epigenetic inactivation of CHFR in human tumors

CpG island methylator phenotype in colorectal cancer

KRAS mutation status is predictive of response to cetuximab therapy in colorectal cancer.

A genetic model for colorectal tumorigenesis

P304

1903-1916

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2217/14622416.9.12.1903

http://www.w3.org/2001/XMLSchema#string

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P50

Manon van Engeland

P577

2008-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23653552

http://www.w3.org/2001/XMLSchema#string

P698

19072647

http://www.w3.org/2001/XMLSchema#string

P921

colorectal cancer